FDA Public Workshop to Discuss Emerging Applications of AI in Radiological Imaging

The US Food and Drug Administration {(FDA) Silver Spring, MD, USA} has announced a public workshop entitled "Evolving Role of Artificial Intelligence in Radiological Imaging" aimed at discussing emerging applications of Artificial Intelligence (AI) in radiological imaging, including AI devices intended to automate the diagnostic radiology workflow as well as guided image acquisition.

Through the workshop, the FDA intends to work with interested stakeholders to identify the benefits and risks associated with use of AI in radiological imaging. As the benefit-risk profile changes, it is critical to adapt the methods used to evaluate and characterize their performance. The agency also plans to discuss best practices for the validation of AI-automated radiological imaging software and image acquisition devices which is critical to assess their safety and effectiveness. The FDA is also seeking innovative and consistent ways to leverage existing methods and to develop new methods for validation of these AI-based algorithms and explore opportunities for stakeholder collaboration in these efforts.

The public workshop will be held on February 25, 2020 from 8:00 a.m. to 5:30 p.m. (EST) and February 26, 2020 from 9 a.m. to 4:30 p.m. (EST) in Maryland, USA

Related Links:
Food and Drug Administration (FDA)